RecruitingNCT07445412

Italian Group of Regenerative and Occlusive Worldwide-used Techniques of Hepatic Hypertrophy

Italian Group of Regenerative and Occlusive Worldwide-used Techniques of Hepatic Hypertrophy - IGROWtoh


Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Enrollment

2,000 participants

Start Date

Oct 22, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this national mutlticenter observational study is to learn and describe trends over time in the use of techniques for inducing hepatic hypertrophy in Italy. Patients will be treated according to the current clinical practice of the participating centers and will be observed from the moment of recruitment and throughout their stay. Information on vital status will be collected, as far as possible, for up to 5 years after surgery in order to record any events that occur in a timely manner. There are also plans to retrospectively collect data on patients who underwent hypertrophic techniques in the previous 10 years, in order to establish a historical cohort for each center that can be used for comparison with the prospective cohort.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Patients aged 18 or older
  • Obtaining informed consent
  • Patients with liver neoplasia (benign or malignant) and with a future liver remnant volume deemed insufficient (\<20%-40%) by the local multidisciplinary team

Exclusion Criteria1

  • pregnant or breastfeeding woman

Locations(1)

IRCCS Azienda Ospedaliero-Universitario di Bologna

Bologna, Bologna, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07445412


Related Trials